The FDA has issued multiple warning letters to Empower over the past several years, documenting concerns about sterile compounding practices, contamination control, and quality assurance procedures
Group design and comparative analysis Comparative safety profile: GLP-1 receptor agonist monotherapy versus combination therapy with metformin The pharmacovigilance analysis encompassed 262,355 adverse event (AE) reports associated with GLP-1 receptor agonist therapy
Those who use many daily actives believe that daytime is good enough, and others find night time more comfortable
While each peptide independently supports the bodys natural growth hormone (GH) production, their combined use leverages complementary mechanisms of action that may produce more robust and balanced results than either peptide alone
Women aged 5064 had the highest use overall, with 20 percent reporting current or past GLP-1 use
Prioritize Sleep and Stress Reduction Poor sleep and high stress can impact the balance of our hormones, including GLP-1